Skip to content

Gut microbiota and its metabolite changes in post-myocardial infarction patients

Gut microbiota and its metabolite changes in post-myocardial infarction patients

Status
Unknown
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20220630001
Enrollment
120
Registered
2022-06-30
Start date
2022-06-13
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute coronary syndrome ACS Gut microbiota Blood metabolites TMAO LPS Troponin

Interventions

The patient had acute myocardial infarction,The patient who had high risk for cardiovascular events.
Diagnostic,Diagnostic
ASC patients,Cardiovascular high risks patients

Sponsors

The faculty of Medicine endowment fund
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Post ACS group 1. Age 18 to 80 years old 2. Diagnosed of acute coronary syndrome (ST-elevation myocardial infarction or non-ST-elevation myocardial infarction) patients receiving coronary angiography or revacularization within 12 to 24 hours at Cardiovascular and Critical Care unit in Maharaj Nakorn Chiang Mai hospital Normal population group 1. Age 18 to 80 years old 2. Healthy volunteer who has age sex and comorbidities matched at Outpatients clinic of Internal medicine department at Maharaj Nakorn Chiang Mai hospital 2.1 Hypertension defined as home BP more than 135 over 85 or on antihypertensive medication 2.2 Diabetes mellitus type 2 defined as HbA1c more than 7 percent or less than 7 percent FBS more than 126 random glucose more than 200 on antidiabetic medication 2.3 Dyslipidemia defined as LDL more than 70 or on anti lipid medication

Exclusion criteria

Exclusion criteria: 1. Cardiac arrest and cannot be recover 2. Life expectancy less than 1 year 3. History of acute cardiovascular events (including acute coronary syndrome, stroke, heart failure, acute/critical limb ischemia) 4. History of heart failure reduced ejection fraction 5. History of antibiotics or probiotics in past 4 weeks before recruitment 6. Active infection within 1 week 7. Severe valvular heart disease 8. Informed consent refusal

Design outcomes

Primary

MeasureTime frame
Gut microbiota species and blood metabolites 3 months species and diversity

Secondary

MeasureTime frame
- Gut and blood microbiota association in individual patients with acute coronary syndrome at 0 and 3 months 3 months not statistical method

Countries

Thailand

Contacts

Public ContactNutnicha Suntornlekha

Faculty of Medicine, Chiang Mai University

iris.nutnicha@gmail.com0855305156

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026